Deadly shooting at Austin Target store leaves 3 dead, suspect arrested after carjacking spree
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Deadly shooting at Austin Target store leaves 3 dead, suspect arrested after carjacking spree
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
